{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:33:04Z","timestamp":1788489184828,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T00:00:00Z","timestamp":1633305600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005689","name":"G\u00f6teborg Medical Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005689","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.msard.2021.103288","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T21:50:10Z","timestamp":1632779410000},"page":"103288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Follow-up after infectious mononucleosis in search of serological similarities with presymptomatic multiple sclerosis"],"prefix":"10.1016","volume":"56","author":[{"given":"Daniel","family":"Jons","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linn","family":"Persson Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Sundstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Haghighi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Axelsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e5ns","family":"Thulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Bergstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluf","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.msard.2021.103288_bib0001","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/jnnp-2020-322941","article-title":"Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis","volume":"91","author":"Abrahamyan","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"19","key":"10.1016\/j.msard.2021.103288_bib0002","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1056\/NEJMoa066092","article-title":"Duration of humoral immunity to common viral and vaccine antigens","volume":"357","author":"Amanna","year":"2007","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.msard.2021.103288_bib0003","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1001\/jama.286.24.3083","article-title":"Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study","volume":"286","author":"Ascherio","year":"2001","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.msard.2021.103288_bib0004","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1086\/491740","article-title":"A prospective clinical study of Epstein-Barr virus and host interactions during acute infectious mononucleosis","volume":"192","author":"Balfour","year":"2005","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.msard.2021.103288_bib0005","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/infdis\/jis646","article-title":"Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students","volume":"207","author":"Balfour","year":"2013","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.msard.2021.103288_bib0006","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/ene.14597","article-title":"Epstein-Barr virus infection after adolescence and human herpesvirus 6A as risk factors for multiple sclerosis","volume":"28","author":"Bistrom","year":"2021","journal-title":"Eur J Neurol"},{"issue":"28","key":"10.1016\/j.msard.2021.103288_bib0007","doi-asserted-by":"crossref","first-page":"7864","DOI":"10.1073\/pnas.1522730113","article-title":"Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins","volume":"113","author":"Brandle","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.msard.2021.103288_bib0008","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1128\/CVI.00674-15","article-title":"Kinetics of Epstein-Barr Virus (EBV) Neutralizing and Virus-Specific Antibodies after Primary Infection with EBV","volume":"23","author":"Bu","year":"2016","journal-title":"Clin Vaccine Immunol"},{"issue":"7","key":"10.1016\/j.msard.2021.103288_bib0009","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1086\/528993","article-title":"Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up","volume":"197","author":"Davidkin","year":"2008","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.msard.2021.103288_bib0010","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1001\/archneur.63.6.noc50328","article-title":"Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up","volume":"63","author":"DeLorenze","year":"2006","journal-title":"Arch Neurol"},{"issue":"22","key":"10.1016\/j.msard.2021.103288_bib0011","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92724","article-title":"Clonal relationships of CSF B cells in treatment-naive multiple sclerosis patients","volume":"2","author":"Eggers","year":"2017","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.msard.2021.103288_bib0012","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.18388\/abp.2003_3644","article-title":"Paul-Bunnell antigen and a possible mechanism of formation of heterophile antibodies in patients with infectious mononucleosis","volume":"50","author":"Golaszewska","year":"2003","journal-title":"Acta Biochim Pol"},{"issue":"3","key":"10.1016\/j.msard.2021.103288_bib0013","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1182\/blood-2007-06-093278","article-title":"On the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosis","volume":"111","author":"Hadinoto","year":"2008","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.msard.2021.103288_bib0014","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1007\/s004150070130","article-title":"Incidence of CSF abnormalities in siblings of multiple sclerosis patients and unrelated controls","volume":"247","author":"Haghighi","year":"2000","journal-title":"J Neurol"},{"issue":"3","key":"10.1016\/j.msard.2021.103288_bib0015","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1574-695X.1994.tb00446.x","article-title":"Viral antibodies in infectious mononucleosis","volume":"8","author":"Haukenes","year":"1994","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"10","key":"10.1016\/j.msard.2021.103288_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003685","article-title":"The cycle of EBV infection explains persistence, the sizes of the infected cell populations and which come under CTL regulation","volume":"9","author":"Hawkins","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.msard.2021.103288_bib0017","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.3389\/fneur.2019.01368","article-title":"High Levels of Epstein-Barr Virus Nuclear Antigen-1-Specific Antibodies and Infectious Mononucleosis Act Both Independently and Synergistically to Increase Multiple Sclerosis Risk","volume":"10","author":"Hedstrom","year":"2019","journal-title":"Front Neurol"},{"issue":"10","key":"10.1016\/j.msard.2021.103288_bib0018","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1128\/JVI.78.10.5194-5204.2004","article-title":"Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells","volume":"78","author":"Hochberg","year":"2004","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.msard.2021.103288_bib0019","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12883-018-1018-3","article-title":"The MRZ reaction helps to distinguish rheumatologic disorders with central nervous involvement from multiple sclerosis","volume":"18","author":"Hottenrott","year":"2018","journal-title":"BMC Neurol"},{"key":"10.1016\/j.msard.2021.103288_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577314","article-title":"Antibodies to Epstein-Barr virus and neurotropic viruses in multiple sclerosis and optic neuritis","volume":"346","author":"Houen","year":"2020","journal-title":"J Neuroimmunol"},{"issue":"3","key":"10.1016\/j.msard.2021.103288_bib0021","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00415-016-8360-4","article-title":"The MRZ reaction as a highly specific marker of multiple sclerosis: re-evaluation and structured review of the literature","volume":"264","author":"Jarius","year":"2017","journal-title":"J Neurol"},{"key":"10.1016\/j.msard.2021.103288_bib0022","doi-asserted-by":"crossref","DOI":"10.1111\/ane.13280","article-title":"Intrathecal immunoreactivity in people with or without previous infectious mononucleosis","author":"Jons","year":"2020","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.msard.2021.103288_bib0023","doi-asserted-by":"crossref","unstructured":"Koenker, R., 2005. Quantile Regression Cambridge University Press.","DOI":"10.1017\/CBO9780511754098"},{"issue":"7850","key":"10.1016\/j.msard.2021.103288_bib0024","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0140-6736(74)92496-9","article-title":"Very high measles and rubella virus antibody titres associated with hepatitis, systemic lupus erythematosus, and infectious mononucleosis","volume":"1","author":"Laitinen","year":"1974","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.msard.2021.103288_bib0025","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/NEN.0b013e31827bfc62","article-title":"B-cell enrichment and Epstein-Barr virus infection in inflammatory cortical lesions in secondary progressive multiple sclerosis","volume":"72","author":"Magliozzi","year":"2013","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.msard.2021.103288_bib0026","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3389\/fmicb.2018.00454","article-title":"Epstein-Barr Virus Acquires Its Final Envelope on Intracellular Compartments With Golgi Markers","volume":"9","author":"Nanbo","year":"2018","journal-title":"Front Microbiol"},{"issue":"19","key":"10.1016\/j.msard.2021.103288_bib0027","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1038\/sj.emboj.7601853","article-title":"The coupling of synthesis and partitioning of EBV's plasmid replicon is revealed in live cells","volume":"26","author":"Nanbo","year":"2007","journal-title":"EMBO J"},{"key":"10.1016\/j.msard.2021.103288_bib0028","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-1-4939-6655-4_2","article-title":"Epstein-Barr Virus: Clinical Diagnostics","volume":"1532","author":"Niller","year":"2017","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.msard.2021.103288_bib0029","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.mehy.2016.04.025","article-title":"Antibody producing B lineage cells invade the central nervous system predominantly at the time of and triggered by acute Epstein-Barr virus infection: A hypothesis on the origin of intrathecal immunoglobulin synthesis in multiple sclerosis","volume":"91","author":"Otto","year":"2016","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.msard.2021.103288_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2020.113927","article-title":"Recombinant Epstein-Barr virus glycoprotein 350 as a serological antigen","volume":"284","author":"Persson Berg","year":"2020","journal-title":"J Virol Methods"},{"issue":"1","key":"10.1016\/j.msard.2021.103288_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2014.06.011","article-title":"Elevated antibody reactivity to measles virus NCORE protein among patients with multiple sclerosis and their healthy siblings with intrathecal oligoclonal immunoglobulin G production","volume":"61","author":"Persson","year":"2014","journal-title":"J Clin Virol"},{"issue":"7","key":"10.1016\/j.msard.2021.103288_bib0033","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/clinchem\/37.7.1153","article-title":"Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain","volume":"37","author":"Reiber","year":"1991","journal-title":"Clin Chem"},{"issue":"3","key":"10.1016\/j.msard.2021.103288_bib0034","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/135245859800400304","article-title":"The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis","volume":"4","author":"Reiber","year":"1998","journal-title":"Mult Scler"},{"issue":"12","key":"10.1016\/j.msard.2021.103288_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226436","article-title":"Primary Epstein-Barr virus infection with and without infectious mononucleosis","volume":"14","author":"Rostgaard","year":"2019","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.msard.2021.103288_bib0036","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1080\/1744666X.2021.1847642","article-title":"The role of Epstein-Barr virus in the etiology of multiple sclerosis: a current review","volume":"16","author":"Ruprecht","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"issue":"2","key":"10.1016\/j.msard.2021.103288_bib0037","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00415-017-8656-z","article-title":"Low intrathecal antibody production despite high seroprevalence of Epstein-Barr virus in multiple sclerosis: a review of the literature","volume":"265","author":"Ruprecht","year":"2018","journal-title":"J Neurol"},{"issue":"8","key":"10.1016\/j.msard.2021.103288_bib0038","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1177\/1352458511433920","article-title":"Epstein-Barr virus neutralizing antibody levels and risk of multiple sclerosis","volume":"18","author":"Simon","year":"2012","journal-title":"Mult Scler"},{"issue":"12","key":"10.1016\/j.msard.2021.103288_bib0039","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1212\/01.WNL.0000130496.51156.D7","article-title":"An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study","volume":"62","author":"Sundstrom","year":"2004","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.msard.2021.103288_bib0040","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jviromet.2011.04.014","article-title":"Recombinant glycoprotein E produced in mammalian cells in large-scale as an antigen for varicella-zoster-virus serology","volume":"175","author":"Thomsson","year":"2011","journal-title":"J Virol Methods"},{"key":"10.1016\/j.msard.2021.103288_bib0041","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3389\/fimmu.2020.00760","article-title":"B and T Cells Driving Multiple Sclerosis: Identity, Mechanisms and Potential Triggers","volume":"11","author":"van Langelaar","year":"2020","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.msard.2021.103288_bib0042","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01562-16","article-title":"High Epstein-Barr Virus Load and Genomic Diversity Are Associated with Generation of gp350-Specific Neutralizing Antibodies following Acute Infectious Mononucleosis","volume":"91","author":"Weiss","year":"2017","journal-title":"J Virol"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034821005551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034821005551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:59:16Z","timestamp":1761901156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034821005551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":41,"alternative-id":["S2211034821005551"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2021.103288","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Follow-up after infectious mononucleosis in search of serological similarities with presymptomatic multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2021.103288","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103288"}}